BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 16956916)

  • 41. [The prediction of atrial fibrillation recurrence after electrical cardioversion with P wave signal averaged EKG].
    Budeus M; Hennersdorf M; Perings C; Strauer BE
    Z Kardiol; 2004 Jun; 93(6):474-8. PubMed ID: 15252741
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reverse atrial electrical remodelling following atrial defibrillation as determined by signal-averaged ECG.
    Healey JS; Theoret-Patrick P; Green MS; Lemery R; Birnie D; Tang AS
    Can J Cardiol; 2004 Mar; 20(3):311-5. PubMed ID: 15054511
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is there a place for the late cardioversion of atrial fibrillation? A long-term follow-up study of patients with post-thyrotoxic atrial fibrillation.
    Nakazawa H; Lythall DA; Noh J; Ishikawa N; Sugino K; Ito K; Hardman SM
    Eur Heart J; 2000 Feb; 21(4):327-33. PubMed ID: 10653681
    [TBL] [Abstract][Full Text] [Related]  

  • 44. One-year outcome of cardioversion of atrial fibrillation in patients with mitral stenosis after percutaneous balloon mitral valvuloplasty.
    Krittayaphong R; Chotinaiwatarakul C; Phankingthongkum R; Panchavinnin P; Tresukosol D; Jakrapanichakul D; Sriratanasathavorn C; Kitrattana B; Kangkagate C
    Am J Cardiol; 2006 Apr; 97(7):1045-50. PubMed ID: 16563913
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Spectral turbulence analysis of the signal-averaged electrocardiogram of the atrial activation as predictor of recurrence of idiopathic and persistent atrial fibrillation.
    Benchimol Barbosa PR; de Souza Bomfim A; Barbosa EC; Ginefra P; Helena Cardoso Boghossian S; Destro C; Nadal J
    Int J Cardiol; 2006 Mar; 107(3):307-16. PubMed ID: 15919123
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enhancing electrical cardioversion and preventing immediate reinitiation of hemodynamically deleterious atrial fibrillation with class III drug pretreatment.
    Hayashi M; Tanaka K; Kato T; Morita N; Sato N; Yasutake M; Kobayashi Y; Takano T
    J Cardiovasc Electrophysiol; 2005 Jul; 16(7):740-7. PubMed ID: 16050832
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Effects of pretreatment with amiodarone infusion in patients with persistent atrial fibrillation submitted to external electrical cardioversion: a single center experience].
    Maffè S; Paffoni P; Perucca A; Dellavesa P; Parravicini U; Nicali R; Bielli M; Paino AM; Signorotti F; Franchetti Pardo N; Zenone F; Zanetta M
    G Ital Cardiol (Rome); 2008 Jul; 9(7):504-8. PubMed ID: 18678217
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Low atrial fibrillatory rate is associated with spontaneous conversion of recent-onset atrial fibrillation.
    Choudhary MB; Holmqvist F; Carlson J; Nilsson HJ; Roijer A; Platonov PG
    Europace; 2013 Oct; 15(10):1445-52. PubMed ID: 23515337
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Supraventricular ectopy and recurrence of atrial fibrillation after electrical cardioversion.
    Chong JJ; Kumar S; Thomas L; Thomas S
    Europace; 2006 May; 8(5):341-4. PubMed ID: 16635992
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Predictors of efficacy initial low energy of external rectilinear biphasic cardioversion in persistent atrial fibrillation].
    Górecki AI; Stec S; Kucharska I; Wełnicki M; Zaborska B; Kryński T; Kułakowski P
    Pol Merkur Lekarski; 2007 Dec; 23(138):408-12. PubMed ID: 18432122
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Relationship between duration of arrhythmia and subsequent preventive effect of disopyramide after cardioversion in patients with symptomatic paroxysmal and persistent atrial fibrillation].
    Komatsu T; Yomogida K; Nakamura S; Suzuki O; Horiuchi D; Kameda K; Tomita H; Abe N; Owada S; Oikawa K; Okumura K
    J Cardiol; 2003 Sep; 42(3):111-7. PubMed ID: 14526660
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Self-limited bursts of atrial fibrillation following successful cardioversion.
    Nergårdh AK; Rosenqvist M; Frick M
    Int J Cardiol; 2007 Jun; 119(1):95-100. PubMed ID: 17064786
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of biphasic electrical cardioversion of atrial fibrillation on early recurrent atrial fibrillation and shock efficacy.
    Siaplaouras S; Buob A; Rötter C; Böhm M; Jung J
    J Cardiovasc Electrophysiol; 2004 Aug; 15(8):895-7. PubMed ID: 15333081
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relapse and mortality following cardioversion of new-onset vs. recurrent atrial fibrillation and atrial flutter in the elderly.
    Elesber AA; Rosales AG; Herges RM; Shen WK; Moon BS; Malouf JF; Ammash NM; Somers V; Hodge DO; Gersh BJ; Hammill SC; Friedman PA
    Eur Heart J; 2006 Apr; 27(7):854-60. PubMed ID: 16455671
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prolonged signal-averaged P wave duration after elective cardioversion increases the risk of recurrent atrial fibrillation.
    Dixen U; Joens C; Parner J; Rasmussen V; Pehrson SM; Jensen GB
    Scand Cardiovasc J; 2004 Jun; 38(3):147-51. PubMed ID: 15223712
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High sensitivity C-reactive protein: a novel predictor for recurrence of atrial fibrillation after successful cardioversion.
    Malouf JF; Kanagala R; Al Atawi FO; Rosales AG; Davison DE; Murali NS; Tsang TS; Chandrasekaran K; Ammash NM; Friedman PA; Somers VK
    J Am Coll Cardiol; 2005 Oct; 46(7):1284-7. PubMed ID: 16198844
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rhythm versus rate control in the contemporary management of atrial fibrillation in-hospital.
    Allen Lapointe NM; Sun JL; Kaplan S; d'Almada P; Al-Khatib SM
    Am J Cardiol; 2008 Apr; 101(8):1134-41. PubMed ID: 18394447
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of the post-cardioversion time course of hs-CRP levels in clarifying the relationship between inflammation and persistence of atrial fibrillation.
    Kallergis EM; Manios EG; Kanoupakis EM; Mavrakis HE; Kolyvaki SG; Lyrarakis GM; Chlouverakis GI; Vardas PE
    Heart; 2008 Feb; 94(2):200-4. PubMed ID: 17575330
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biphasic transoesophageal vs. transthoracic electrical cardioversion of persistent atrial fibrillation.
    Mazza A; Fera MS; Pugliese M; Leggio M; Bendini MG; Poli V; Manzara C; Minardi G; Pino PG; Pompa D; Fiorella AT; De Santis F; Giovannini E
    J Cardiovasc Med (Hagerstown); 2006 Aug; 7(8):594-600. PubMed ID: 16858238
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy of transesophageal echocardiography-guided cardioversion of patients with atrial fibrillation at 6 months: a randomized controlled trial.
    Klein AL; Grimm RA; Jasper SE; Murray RD; Apperson-Hansen C; Lieber EA; Black IW; Davidoff R; Erbel R; Halperin JL; Orsinelli DA; Porter TR; Stoddard MF;
    Am Heart J; 2006 Feb; 151(2):380-9. PubMed ID: 16442904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.